Delivery Order SPE2DB20D3103-SPE2DB24FN2F8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $14,841.40 and runs through February 22, 2023. It is a firm-fixed-price delivery order, with no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,818.48 firm-fixed-price delivery order is for the supply of 4,560,862,411 units of Plaquenil 200 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,909.44 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat certain types of malaria, lupus, and arthritis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $113,239.37 and is a Firm Fixed Price contract type, with an ultimate completion date of August 22, 2024. The contract was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,922.90 firm fixed-price delivery order is for the supply of 4,566,136 units of Plaquenil 200 mg tablets. The contract has an ultimate completion date of October 18, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.16 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.49 to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets in quantities of 100 units. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, operates under firm fixed pricing with no set-aside designation, indicating open and competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2F8Delivery Order
This federal contract award, valued at $7,770.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, rheumatoid arthritis, and lupus. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed does not have a set-aside designation, indicating open competition. The contract delivery location is Conshohocken, PA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 3/29/24 |